Skip to main content
Top
Published in: Pediatric Radiology 12/2018

Open Access 01-11-2018 | Original Article

Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children’s Oncology Group protocol AHOD0031

Authors: Kathleen M. McCarten, Monika L. Metzger, Richard A. Drachtman, Qinglin Pei, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly

Published in: Pediatric Radiology | Issue 12/2018

Login to get access

Abstract

Background

Pleural effusion at presentation in Hodgkin lymphoma has been associated with inferior outcome but has not been systematically evaluated.

Objective

To determine whether pleural effusion at presentation in children with Hodgkin lymphoma is a primary indicator of poor prognosis or secondary to associated factors.

Materials and methods

Children’s Oncology Group (COG) AHOD0031, a randomized, response-based, centrally reviewed protocol, enrolled 1,712 eligible patients <22 years of age with initial presentation of intermediate risk, biopsy-proven Hodgkin lymphoma; 1,423 had available imaging for retrospective review. We coded effusions as fluid-only or with associated pleural nodule or adjacent lung or bone involvement and correlated this with disease stage, tumor response, large mediastinal adenopathy, and mass effect on the superior vena cava (SVC) and left innominate vein. We recorded change in size and character of effusions post-chemotherapy.

Results

Pleural effusions were present in 217, with 204 having fluid-only and 13 having associated solid components. Patients with effusions were more likely to have large mediastinal adenopathy (P<0.0001), be slow early responders (P<0.0001) and have higher relapse rate (P<0.0001). Vascular compression was not significantly correlated with pleural effusion. Of 121 patients with adequate [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT imaging, no FDG PET avidity was seen in any pleural effusion but was present in solid components. The side of the pleural effusion in those with moderate or large effusions was highly associated with the side of large mediastinal adenopathy (P<0.0001). Statistical analysis indicates that pleural effusion is an independent risk factor for poorer response and relapse.

Conclusion

Pleural effusion in Hodgkin lymphoma is an important independent poor prognostic indicator for response and relapse.
Literature
1.
go back to reference Hunter BD, Dhakal S, Voci S et al (2014) Pleural effusions in patients with Hodgkin lymphoma: clinical predictors and associations with outcome. Leuk Lymphoma 55:1822–1826CrossRef Hunter BD, Dhakal S, Voci S et al (2014) Pleural effusions in patients with Hodgkin lymphoma: clinical predictors and associations with outcome. Leuk Lymphoma 55:1822–1826CrossRef
2.
go back to reference Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347CrossRef Das DK (2006) Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 34:335–347CrossRef
3.
go back to reference Toma P, Granata C, Rossi A, Garaventa A (2007) Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children. Radiographics 27:1335–1354CrossRef Toma P, Granata C, Rossi A, Garaventa A (2007) Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children. Radiographics 27:1335–1354CrossRef
4.
go back to reference Chaignaud BE, Bonsack TA, Kozakewich HP, Shamberger RC (1998) Pleural effusions in lymphoblastic lymphoma: a diagnostic alternative. J Pediatr Surg 33:1355–1357CrossRef Chaignaud BE, Bonsack TA, Kozakewich HP, Shamberger RC (1998) Pleural effusions in lymphoblastic lymphoma: a diagnostic alternative. J Pediatr Surg 33:1355–1357CrossRef
5.
go back to reference Filly R, Bland N, Castellino RA (1976) Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 120:277–281CrossRef Filly R, Bland N, Castellino RA (1976) Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 120:277–281CrossRef
6.
go back to reference Castellino RA, Blank N, Hoppe RT, Cho C (1986) Hodgkin disease: contributions of chest CT in the initial staging evaluation. Radiology 160:603–605CrossRef Castellino RA, Blank N, Hoppe RT, Cho C (1986) Hodgkin disease: contributions of chest CT in the initial staging evaluation. Radiology 160:603–605CrossRef
7.
go back to reference Hoppe R (2007) Hodgkin lymphoma, 2nd edn. Wolters Kluwer/ Lippincott Williams & Wilkins, Philadelphia Hoppe R (2007) Hodgkin lymphoma, 2nd edn. Wolters Kluwer/ Lippincott Williams & Wilkins, Philadelphia
8.
go back to reference Mauch P (1999) Hodgkin's disease. Lippincott Williams & Wilkins, Philadelphia Mauch P (1999) Hodgkin's disease. Lippincott Williams & Wilkins, Philadelphia
9.
go back to reference Guermazi A, Brice P, de Kerviler EE et al (2001) Extranodal Hodgkin disease: spectrum of disease. Radiographics 21:161–179CrossRef Guermazi A, Brice P, de Kerviler EE et al (2001) Extranodal Hodgkin disease: spectrum of disease. Radiographics 21:161–179CrossRef
10.
go back to reference Janjetovic S, Janning M, Daukeva L et al (2013) Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. Tumori 99:e96–e99CrossRef Janjetovic S, Janning M, Daukeva L et al (2013) Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. Tumori 99:e96–e99CrossRef
11.
go back to reference Tutor JD (2014) Chylothorax in infants and children. Pediatrics 133:722–733CrossRef Tutor JD (2014) Chylothorax in infants and children. Pediatrics 133:722–733CrossRef
12.
go back to reference Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269–291CrossRef Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269–291CrossRef
13.
go back to reference Sahn SA (1998) Malignant pleural effusions. In: Fishman AP, Elias JA, Fishman JA et al (eds) Fishman’s pulmonary diseases and disorders, 3rd edn. McGraw Hill, New York, pp 1429–1439 Sahn SA (1998) Malignant pleural effusions. In: Fishman AP, Elias JA, Fishman JA et al (eds) Fishman’s pulmonary diseases and disorders, 3rd edn. McGraw Hill, New York, pp 1429–1439
14.
go back to reference Bonomo L, Feragalli B, Sacco R et al (2000) Malignant pleural disease. Eur J Radiol 34:98–118CrossRef Bonomo L, Feragalli B, Sacco R et al (2000) Malignant pleural disease. Eur J Radiol 34:98–118CrossRef
15.
go back to reference Light RW (2007) Pleural effusions related to metastatic malignancies. In: Pleural diseases, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 134–162 Light RW (2007) Pleural effusions related to metastatic malignancies. In: Pleural diseases, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 134–162
17.
go back to reference Tateishi U, Muller NL, Johkoh T et al (2004) Primary mediastinal lymphoma: characteristic features of the various histological subtypes on CT. J Comput Assist Tomogr 28:782–789CrossRef Tateishi U, Muller NL, Johkoh T et al (2004) Primary mediastinal lymphoma: characteristic features of the various histological subtypes on CT. J Comput Assist Tomogr 28:782–789CrossRef
18.
go back to reference Issa PY, Brihi ER, Janin Y, Slim MS (1983) Superior vena cava syndrome in childhood: report of ten cases and review of the literature. Pediatrics 71:337–341 Issa PY, Brihi ER, Janin Y, Slim MS (1983) Superior vena cava syndrome in childhood: report of ten cases and review of the literature. Pediatrics 71:337–341
19.
go back to reference Ingram L, Rivera GK, Shapiro DN (1990) Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. Med Pediatr Oncol 18:476–481CrossRef Ingram L, Rivera GK, Shapiro DN (1990) Superior vena cava syndrome associated with childhood malignancy: analysis of 24 cases. Med Pediatr Oncol 18:476–481CrossRef
20.
go back to reference Yellin A, Mandel M, Rechavi G et al (1992) Superior vena cava syndrome associated with lymphoma. Am J Dis Child 146:1060–1063PubMed Yellin A, Mandel M, Rechavi G et al (1992) Superior vena cava syndrome associated with lymphoma. Am J Dis Child 146:1060–1063PubMed
21.
go back to reference Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group study AHOD0031. J Clin Oncol 32:3651–3658CrossRef Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group study AHOD0031. J Clin Oncol 32:3651–3658CrossRef
22.
go back to reference Schwartz CL, Chen L, McCarten K et al (2017) Childhood Hodgkin international prognostic score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 64:e26278CrossRef Schwartz CL, Chen L, McCarten K et al (2017) Childhood Hodgkin international prognostic score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 64:e26278CrossRef
Metadata
Title
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children’s Oncology Group protocol AHOD0031
Authors
Kathleen M. McCarten
Monika L. Metzger
Richard A. Drachtman
Qinglin Pei
Debra L. Friedman
Cindy L. Schwartz
Kara M. Kelly
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 12/2018
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-018-4197-6

Other articles of this Issue 12/2018

Pediatric Radiology 12/2018 Go to the issue

Hermes

Hermes